Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Retrospective review of diagnostic medical pleuroscopy in tuberculous pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 421s Year: 2005
VATS as a diagnostic tool in parenchymal, pleural and mediastinal diseases - a retrospective analysis of 650 cases Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001
Late Breaking Abstract - Burden of disease, diagnostic work-up and management of bronchiectasis in outpatient clinics – a five-year prospective cohort study Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
Diagnostic yield and safety of image-guided pleural biopsy: a systematic review and meta-analysis Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020
An audit of the use of Abrams‘ pleural biopsy in the diagnosis of mesothelioma Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pediatric pleural effusions: a retrospective review of 492 patients Source: Eur Respir J 2006; 28: Suppl. 50, 311s Year: 2006
A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
The value of BAL in the assessment of pulmonary sarcoidosis in clinical practice: a retrospective analysis Source: Eur Respir J 2001; 18: Suppl. 33, 68s Year: 2001
The clinical application of medical thoracoscopy in the diagnosis and treatment of multi-locular empyema Source: Annual Congress 2010 - Infections and pleural problems Year: 2010
Surgical mediastinal staging in daily practice. A retrospective analysis in four general hospitals Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004
Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Role of medical pleuroscopy for management of pleural effusion: a 3 years period review Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008
Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Influence of pathologist experience on EBUS-TBNA overall accuracy: A historical cohort study Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope Year: 2018
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Our clinical experience in surgical therapy of 272 patients with bronchiectasis during 15-year period Source: Annual Congress 2008 - Pleuropulmonary infections; thoracic trauma Year: 2008
Diagnostic pleuroscopy and pleuroscopic talc pleurodesis in malignant pleural effusions – a study on efficacy and safety Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009